Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 40 /hr
Hire Dr. Mike L.
United States
USD 40 /hr
Postdoc in Biotherapy (Sichuan Univ.) | Medical & Scientific Writer | Nature Immunology co-first author
Profile Summary
Subject Matter Expertise
Services
Writing
Medical Writing,
General Proofreading & Editing,
Translation
Research
Gray Literature Search,
Scientific and Technical Research,
Systematic Literature Review
Consulting
Healthcare Consulting,
Scientific and Technical Consulting
Work Experience
Sichuan University
- Present ![]()
Postdoctoral Researcher
West China Hospital, Sichuan University
July 2025 - Present
Project Specialist
Sichuan Huiyu Pharmaceutical Co., Ltd.
March 2019 - November 2020
Education
PhD in Human Disease Biotherapy
Sichuan University
September 2021 - June 2025
MS in Stem Cell Biology
University of Minnesota Twin Cities
September 2018 - June 2020
BS in Biological Science
Sichuan Agricultural University
September 2014 - June 2018
Certifications
Publications
JOURNAL ARTICLE
(2026). H3K18 lactylation drives CD8<SUP>+</SUP> T cell exclusion and anti-PD-1 resistance in hepatocellular carcinoma . CELL REPORTS.
(2026). Immunopeptidome profiling in pulmonary fibrosis provides a platform for identifying therapeutic targets . NATURE IMMUNOLOGY.
(2026). Temperature-sensitive liquid embolic agent transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for BCLC Stage B/C hepatocellular carcinoma: a multicenter real-world study and spatial transcriptomics profiling (CHANCE 2515) . SIGNAL TRANSDUCTION AND TARGETED THERAPY.
(2025). A Vaccine Therapy for Idiopathic Pulmonary Fibrosis . EUROPEAN RESPIRATORY JOURNAL.
(2025). GM-CSF-engineered cell vaccine based on myofibroblast for the treatment of pulmonary fibrosis . EUROPEAN RESPIRATORY JOURNAL.
(2025). Immunopeptidiomics profiling in idiopathic pulmonary fibrosis provides a new platform for identifying therapeutic targets . EUROPEAN RESPIRATORY JOURNAL.
(2025). Intranasal MAF peptide vaccine for idiopathic pulmonary fibrosis therapy . EUROPEAN RESPIRATORY JOURNAL.
(2025). The First Vaccine Based Therapy for Idiopathic Pulmonary Fibrosis in Human . AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE.
(2025). The role of lactylation in tumor growth and cancer progression . FRONTIERS IN ONCOLOGY.
(2024). CD44 and its implication in neoplastic diseases . MEDCOMM.
(2024). Engineered mitochondria exert potent antitumor immunity as a cancer vaccine platform . CELLULAR & MOLECULAR IMMUNOLOGY.
(2024). Nanoplatform Based Intranasal Vaccines: Current Progress and Clinical Challenges . ACS NANO.
(2024). Simultaneous enhancement of cellular and humoral immunity by the lymph node-targeted cholesterolized TLR7 agonist liposomes . ACTA PHARMACEUTICA SINICA B.
(2024). The Hippo signalling pathway and its implications in human health and diseases (vol 7, 376, 2022) . SIGNAL TRANSDUCTION AND TARGETED THERAPY.
(2023). ERK inhibitor: A candidate enhancing therapeutic effects of conventional chemo-radiotherapy in esophageal squamous cell carcinoma . CANCER LETTERS.
(2023). Omicron variant: a booster depending on infection histories . SIGNAL TRANSDUCTION AND TARGETED THERAPY.
(2023). Surgical Treatment of Osteosarcoma Induced Distant Pre-Metastatic Niche in Lung to Facilitate the Colonization of Circulating Tumor Cells . ADVANCED SCIENCE.
(2023). TFAM deficiency in dendritic cells leads to mitochondrial dysfunction and enhanced antitumor immunity through cGAS-STING pathway . JOURNAL FOR IMMUNOTHERAPY OF CANCER.
(2022). CCL5/CCR5 axis in human diseases and related treatments . GENES & DISEASES.
(2022). CXCL13 as a Novel Immune Checkpoint for Regulatory B Cells and Its Role in Tumor Metastasis . JOURNAL OF IMMUNOLOGY.
(2022). 'Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases' [Acta pharmaceutica sinica B 12 specialIntscript 1740-1760] (vol 12, page 4525, year 2022) . ACTA PHARMACEUTICA SINICA B.
(2022). Boosting with variant-matched vaccines: an opportunity to win the race against Omicron . SIGNAL TRANSDUCTION AND TARGETED THERAPY.
(2022). Crystalline silica induces macrophage necrosis and causes subsequent acute pulmonary neutrophilic inflammation . CELL BIOLOGY AND TOXICOLOGY.
(2022). Genome editing via non-viral delivery platforms: current progress in personalized cancer therapy . MOLECULAR CANCER.
(2022). Intranasal administration of a recombinant RBD vaccine induces long-term immunity against Omicron-included SARS-CoV-2 variants . SIGNAL TRANSDUCTION AND TARGETED THERAPY.
(2022). Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases . ACTA PHARMACEUTICA SINICA B.
(2022). SARS-CoV-2 Omicron variant: Immune escape and vaccine development . MEDCOMM.
(2022). The Hippo signalling pathway and its implications in human health and diseases . SIGNAL TRANSDUCTION AND TARGETED THERAPY.
(2022). Tripterin liposome relieves severe acute respiratory syndrome as a potent COVID-19 treatment . SIGNAL TRANSDUCTION AND TARGETED THERAPY.
(2022). Tumor-associated neutrophils and neutrophil-targeted cancer therapies . BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER.
(2021). Antitumor and Radiosensitization Effects of a CXCR2 Inhibitor in Nasopharyngeal Carcinoma . FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY.
(2021). Constrained surfaces: promising therapeutic targets for COVID-19 determined by systematically mutational analysis . SIGNAL TRANSDUCTION AND TARGETED THERAPY.
(2021). Inflammatory Cytokines in Cancer: Comprehensive Understanding and Clinical Progress in Gene Therapy . CELLS.
(2021). Inhibition of 15-PDGH: a strategy to rejuvenate aged muscles? . MOLECULAR BIOMEDICINE.
(2021). Lymph-Node-Targeted Cholesterolized TLR7 Agonist Liposomes Provoke a Safe and Durable Antitumor Response . NANO LETTERS.
(2021). Mesenchymal stem/stromal cells in cancer therapy . JOURNAL OF HEMATOLOGY & ONCOLOGY.